Simultaneous Detection of Collagen I Alpha II and Cytokeratin 19 mRNA by Multiplex qPCR in Liquid Biopsy in Diagnosis of Patients with Resectable Solid Tumors

• Published in: International journal of molecular sciences Vol. 25; no. 17; p. 9567
• Main Authors: Estévez Pérez, Lara Sofía, Alén, Begoña O, Otero Alén, María, Hormaetxe, Saioa Domínguez, Simón, Laureano, Concha, Ángel
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 03.09.2024
• Subjects: Adult; Aged; Biomarkers; Biomarkers, Tumor - blood; Biomarkers, Tumor - genetics; Biopsy; Cancer; Case-Control Studies; COL1A2; Collagen; Collagen Type I - blood; Collagen Type I - genetics; Cytokeratin; early detection multi-cancer screening; Early Detection of Cancer - methods; Extracellular vesicles; Female; Fibroblasts; Genes; Humans; Keratin-19 - blood; Keratin-19 - genetics; KRT19; liquid biopsy; Liquid Biopsy - methods; Male; Medical screening; Middle Aged; Multiplex Polymerase Chain Reaction - methods; multiplex RT-qPCR; Neoplasms - blood; Neoplasms - diagnosis; Neoplasms - genetics; Reproducibility; Retrospective Studies; RNA, Messenger - blood; RNA, Messenger - genetics; ROC Curve; Tumors; early detection multi-cancer screening; KRT19; COL1A2; multiplex RT-qPCR; liquid biopsy
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms25179567

The early detection of tumors is one of the key factors in increasing overall survival in cancer patients. A wide range of cancers still do not have a system of early diagnosis; therefore, the development of new non-invasive tools in this line is essential. Accordingly, the objective of our work was to develop a non-invasive screening method for the early detection of various carcinomas in plasma using a panel that combines two markers using RT-qPCR. A retrospective case-control study was conducted to develop a cancer screening test based on the detection of stromal and epithelial biomarkers (COL1A2 and KRT19) in plasma. The expression of biomarkers was evaluated using multiplex quantitative PCR applied to 47 cases with non-metastatic tumors and 13 control participants. For both biomarkers, a cut-off value was stablished using Youden's J index through ROC curve analysis and areas under the curve (AUC) were calculated. The plasma mRNA expression level of both biomarkers was significantly higher in diseased versus healthy patients. Moreover, ROC curve analysis showed an AUC value of 0.897 for the combined model. This model also resulted in a cutoff value of 0.664, as well as a sensitivity of 83% and a specificity of 84.6%. These results suggest that the plasma expression levels of COL1A2 and KRT19 could a have potential role in detecting various types of cancer at the early stages. The combined analysis of both stromal and epithelial biomarkers would provide a non-invasive screening method that would allow us to differentiate patients with an active neoplastic process.